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ABSTRACT
The emergence of craniofacial skeletal elements, and of the jaw in
particular, was a crucial step in the evolution of higher vertebrates.
Most facial bones and cartilage are generated during embryonic
development by cranial neural crest cells, while an
osteochondrogenic fate is suppressed in more posterior neural crest
cells. Key players in this process are Hox genes, which suppress
osteochondrogenesis in posterior neural crest derivatives. How this
specific pattern of osteochondrogenic competence is achieved
remains to be elucidated. Here we demonstrate that Hox gene
expression and osteochondrogenesis are controlled by epigenetic
mechanisms. Ezh2, which is a component of polycomb repressive
complex 2 (PRC2), catalyzes trimethylation of lysine 27 in histone 3
(H3K27me3), thereby functioning as transcriptional repressor of
target genes. Conditional inactivation of Ezh2 does not interfere with
localization of neural crest cells to their target structures, neural
development, cell cycle progression or cell survival. However, loss of
Ezh2 results in massive derepression of Hox genes in neural crest
cells that are usually devoid of Hox gene expression. Accordingly,
craniofacial bone and cartilage formation is fully prevented in Ezh2
conditional knockout mice. Our data indicate that craniofacial skeleton
formation in higher vertebrates is crucially dependent on epigenetic
regulation that keeps in check inhibitors of an osteochondrogenic
differentiation program.
KEY WORDS: Ezh2, Epigenetic regulation, Neural crest,
Chondrogenesis, Osteogenesis, Mouse
INTRODUCTION
Neural crest cells (NCCs) are a transient, multipotent population of
cells that are specified during embryonic development in the neural
tube and then delaminate from the dorsal tip during closure of the
neural tube. NCCs give rise to a variety of neural and non-neural
cell types (Gammill and Bronner-Fraser, 2003). Depending on the
level of emigration along the rostral-caudal axis of the embryo, the
NC can be divided into distinct subpopulations that differ in the cell
fates that they generate. Trunk NCCs build up a large part of the
peripheral nervous system (PNS), including Schwann cells of
peripheral nerves and neurons and glia of sympathetic,
parasympathetic and sensory ganglia (Le Douarin and Dupin, 2012).
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In addition, they give rise to melanocytes (Sommer, 2011) and
endocrine cells (Le Douarin and Dupin, 2012). Cranial neural crest
cells (CNCCs) emigrate from the caudal forebrain, midbrain and
hindbrain to the level of the first somite and give rise to additional
cell fates in comparison to trunk NCCs, contributing to cartilage,
bone and connective tissue (Le Douarin et al., 2007; Santagati and
Rijli, 2003). CNCCs migrate into the branchial arches (BAs),
becoming NC-derived mesenchymal progenitor cells (MPCs), which
produce cartilage and skeletogenic elements of the craniofacial
region. Specific cell fates of CNCCs are controlled by positional
cues that determine intrinsic gene expression patterns that are
partially specified already at emigration from the neural tube.
Central players in this process are the Hox genes that are
differentially expressed in migratory CNCCs and BAs according to
the axial position. In particular, cells in BA1 and anterior domains
are devoid of Hox gene expression, which allows formation of the
chondrogenic and skeletal elements of the facial region (Creuzet et
al., 2002; Kanzler et al., 1998; Minoux and Rijli, 2010). In addition
to these intrinsic cues, CNCC fates are regulated by environmental
signals, such as Tgfβ (Wurdak et al., 2006) and Fgf8 expressed from
the facial and BA ectoderm (Le Douarin et al., 2007; Santagati and
Rijli, 2003). As a consequence of such signaling, expression of the
transcription factor Sox9 is upregulated in MPCs, while expression
levels of the NC specifier gene and NC stem cell (NCSC) marker
Sox10 decrease (John et al., 2011). This switch in Sox transcription
factor expression leads to suppression of neural fates and allows
CNCCs to differentiate into mesectodermal NC derivatives,
including bone, cartilage and smooth muscle.
Polycomb repressive complex 2 (PRC2) is composed of four core
subunits: enhancer of zeste homolog 2 (Ezh2), embryonic ectoderm
development (Eed), suppressor of zeste 12 (Suz12) and RbAp46/48
(Rbbp4/7 in mouse) (Margueron and Reinberg, 2011). Ezh2, with
its SET domain, is the catalytic subunit of PRC2 that catalyzes the
mono-, di- and trimethylation of H3K27 (H3K27me1, H3K27me2
and H3K27me3) (Shen et al., 2008). PRC2 modulates gene
expression via H3K27 trimethylation and acts as a transcriptional
repressor (Mikkelsen et al., 2007; Schuettengruber et al., 2007). In
mammals, PRC2 is involved in repressing developmental regulators
in mouse embryonic stem cells (mESCs) and in regulating the
proliferation and differentiation of stem cells (Boyer et al., 2006;
Margueron and Reinberg, 2011). The importance of epigenetic
modifiers in vertebrate development is evident from the phenotype
of mice lacking Ezh2, which die around gastrulation (O’Carroll et
al., 2001). Later in development, the need for epigenetic modifiers
is stage and time dependent and also functionally distinct from that
in ESCs. For example, neural stem cells that lack Ezh2 exhibit a
prolonged neurogenic phase even though differentiation is not
affected (Hirabayashi et al., 2009). Other experiments have shown
a role for Ezh2 in regulating anterior-posterior axis specification and
proximo-distal axis elongation in the developing limb bud
Ezh2 is required for neural crest-derived cartilage and bone
formation
Daniel Schwarz1,‡, Sandra Varum1,‡, Martina Zemke1, Anne Schöler2,*, Arianna Baggiolini1, Kalina Draganova1,
Haruhiko Koseki3, Dirk Schübeler2,4 and Lukas Sommer1,§
D
ev
el
op
m
en
t
868
(Wyngaarden et al., 2011). Furthermore, Soshnikova and Duboule
demonstrated H3K27me3 occupancy over the HoxD gene cluster in
the developing tail bud of mice, which points to direct regulation of
developmental regulators by epigenetic modifications and, more
specifically, an involvement of Ezh2 (Soshnikova and Duboule,
2009). Evidence for a direct regulation of NCCs by epigenetic
modifiers comes from the work of Strobl-Mazzulla and colleagues,
who showed direct regulation of Sox10 by the histone demethylase
Jmjd2a (Kdm4a in mouse) (Strobl-Mazzulla et al., 2010).
These findings suggest that the regulation of NCC specification,
migration, proliferation and differentiation is at least partially
dependent on epigenetic regulators and modifiers, although the
specific factors and modifications directly involved in the epigenetic
regulation of NC development remain to be determined. In the
present study, we examined the role of Ezh2 in NC development by
conditionally ablating Ezh2 in premigratory NCCs in vivo.
Surprisingly, loss of Ezh2-mediated H3K27 trimethylation had no
overt effect on NCC migration and PNS formation. Likewise,
establishment of MPCs in BAs and the cell cycle properties of
MPCs were not impaired. By contrast, NC-derived craniofacial
structures failed to form from MPCs, which was accompanied by
derepression of Hox genes in CNCCs lacking Ezh2. This phenotype
demonstrates a highly specific role of Ezh2 in NCC subpopulations
and points to a crucial involvement of epigenetic control
mechanisms in the development of jawed vertebrates.
RESULTS
Inactivation of Ezh2 in NCCs
In order to address the in vivo role of Ezh2 during NC development,
we mated mice homozygous for the floxed allele of Ezh2
(Hirabayashi et al., 2009) with mice heterozygous for the floxed allele
that additionally carried a transgene expressing Cre recombinase
under the Wnt1 promoter (Danielian et al., 1998) (supplementary
material Fig. S1A). Ezh2 conditional knockout (cko) mice survived to
late developmental stages, but were never born. To determine the loss
of Ezh2 transcripts, we performed quantitative RT-PCR of mRNA
isolated from BA1 cells. We used two different primer sets, one
targeting Ezh2 exons 18 and 19 and the other exons 5 to 8 (Ezh2 E18-
19 and Ezh2 E5-8). The Ezh2 E18-19 primers recognize sequences in
the mRNA transcript that encode part of the SET domain, whereas the
Ezh2 E5-8 primer set targets a sequence 5′ to the SET domain. Both
quantitative RT-PCR reactions showed a comparable and significant
reduction of the Ezh2 mRNA transcript in Ezh2 cko embryos
compared with controls (supplementary material Fig. S1B).
To track the fate of NCCs lacking Ezh2 upon Cre-mediated gene
deletion, we used the ROSA26 Cre reporter allele (R26R) (Soriano,
1999). In mice carrying this allele, all NCCs express β-galactosidase
due to Wnt1-Cre-dependent recombination (Chai et al., 2000; Hari
et al., 2002). First, we examined changes in the main functional
readout of Ezh2 activity by performing immunohistochemistry for
H3K27me3. In the trunk of Ezh2 cko embryos at embryonic day (E)
9.5, virtually all migratory NCCs identified by β-galactosidase
expression lacked H3K27me3, in contrast to control embryos
(Fig. 1A-C). Likewise, Ezh2-dependent H3K27me3 was lost in
NCCs populating the BA1 of Ezh2 cko embryos (Fig. 1D-F). Taken
together, these results demonstrate efficient inactivation of Ezh2 in
NC-derived cells upon conditional knockout of Ezh2 in NCCs.
Migration of NCCs and their localization to target structures
are not impaired by loss of Ezh2
In vivo fate mapping of NCCs by means of the ROSA26 Cre reporter
allele did not reveal any differences between Ezh2 cko and control
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Fig. 1. Migration of NCCs to their target structures is not impaired by
loss of Ezh2. (A-F) Wnt1-Cre-mediated ablation of Ezh2 results in loss of
H3K27me3 in mouse E9.5 neural crest stem cells (NCSCs). To detect
NCSCs lacking Ezh2 upon Cre-mediated recombination we used the R26R
Cre reporter allele. In contrast to control NCSCs, both trunk (A-C) and BA1
(D-F) Ezh2 mutant NCSCs lacked H3K27me3 by E9.5. Arrowheads
indicate regions magnified in insets. (G,H) In vivo fate mapping of neural
crest cells (NCCs) in E10.5 control and Ezh2 cko embryos. NCCs
expressing β-galactosidase were visualized by X-Gal whole-mount
staining. Both genotypes show a comparable localization of NCCs to their
supposed target structures. (I,J) In vivo fate mapping of NCCs in E14.5
embryos with the R26R Cre reporter allele, indicating a severe loss of
almost all craniofacial derivatives of cranial neural crest cells (CNCCs).
(K,L) Higher magnification of the caudal part of the E14.5 control and Ezh2
cko embryos shown in I and J. Peripheral nerves are present in both
genotypes (arrowheads), indicating normal development of peripheral
nerves. BA, branchial arch. HL, hind limbs. Scale bars: 50 μm in A-F; 2 mm
in G-J; 1 mm in K,L. D
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embryos stained with X-Gal for β-galactosidase activity. NCCs
lacking Ezh2 migrated to and populated the structures normally built
up by NCCs, such as the BAs and dorsal root ganglia (DRG) (Fig.
1G,H). At E11.5, it was still not possible to macroscopically
distinguish Ezh2 cko embryos from control embryos (data not
shown). These results suggest that early events of NC specification
and migration to the respective targets are not profoundly affected
by the loss of Ezh2 in NCCs.
However, Ezh2 cko embryos displayed an overt, macroscopically
detectable phenotype from E12.5 onwards, as illustrated by X-Gal
staining of E14.5 embryos carrying the R26R allele (Fig. 1I,J).
Whereas analysis at hindlimb levels pointed to normal development
of peripheral nerves in Ezh2 cko embryos (Fig. 1K,L, arrowheads),
mutant embryos exhibited severe craniofacial malformations,
despite the presence of residual β-galactosidase-expressing cells in
the nasofrontal area (Fig. 1I,J). Thus, Ezh2 activity appears to be
dispensable for proper localization of NCCs to target tissues and
their long-term survival, but is required for the morphogenesis of
particular NC derivatives.
Ezh2 is not required for neuronal and glial differentiation of
NCCs
To assess the role of Ezh2 in trunk NCC differentiation we
performed immunohistochemistry staining on transverse sections
of Ezh2 cko and control embryos at E11.5. Quantification revealed
that the number of cells in the forming DRG expressing Sox10, a
marker for NCSCs and the glial lineage, was unaltered upon
conditional Ezh2 ablation (Fig. 2A-C). Likewise, the neuronal
marker neurofilament 160 (NF160; Nefm – Mouse Genome
Informatics) was expressed normally in Ezh2 cko embryos at this
stage. In DRG at E17.5, absence of H3K27me3 confirmed the
persistent loss of Ezh2 activity in Ezh2 cko embryos compared
with control littermates (Fig. 2D,E). Expression analysis of the
sensory neuronal differentiation marker Brn3a (Pou4f1 – Mouse
Genome Informatics) (Eng et al., 2004) and of NF160 did not
reveal any differences between Ezh2 cko and control embryos
(Fig. 2F,G). Likewise, satellite cell formation and differentiation
appeared to be normal in DRG lacking Ezh2. Indeed,
immunohistochemistry for glial fibrillary acidic protein (Gfap), a
869
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Fig. 2. Loss of H3K27me3 does not interfere with
the differentiation of trunk NCCs. (A-
C) Immunohistochemistry and quantification of Sox10+
cells indicates that conditional ablation of Ezh2 in the
NC does not hinder Sox10 expression in the forming
dorsal root ganglia (DRG) of E11.5 Ezh2 cko embryos.
Loss of H3K27me3 is maintained during development
of Ezh2 cko embryos as shown by H3K27me3
immunohistochemistry for E17.5 DRG (D,E) and
autonomic ganglia (AG) (J,K). Nonetheless, Ezh2 cko
and control embryos express similar levels of the late
stage neuronal marker NF160 in the DRG (D-G), as
well as similar levels of the dopaminergic neuronal
marker TH in the AG (J-O,S). (F,G,R) Additionally, Ezh2
cko DRG contain similar numbers of cells positive for
the sensory progenitor marker Brn3a when compared
with control DRGs. (H,I) The satellite glial marker Gfap
was expressed in a similar fashion in control and Ezh2
cko embryos. (L,M) Also, the autonomic progenitor
marker Mash1 was found to be expressed similarly in
control and Ezh2 cko. (P,Q,T) Peripheral nerves,
highlighted by NF160, of E17.5 control and Ezh2 cko
embryos express similar levels of the immature
Schwann cell marker Oct6. Data are presented as
mean percentage of positive cells/DAPI ± s.e.m. Scale
bars: 50 μm.
D
ev
el
op
m
en
t
870
late marker of glial differentiation, and staining for fatty acid
binding protein (FABP), an early marker of the glial lineage, did
not reveal any alterations at E17.5 after Ezh2 ablation in the NC
(Fig. 2H,I; data not shown).
As in DRG, we found the expected loss of Ezh2-mediated histone
methylation in autonomic ganglia (AG) of Ezh2 cko embryos at
E17.5 (Fig. 2J,K). However, Mash1 (Ascl1 – Mouse Genome
Informatics), a progenitor marker for autonomic neurons, and
tyrosine hydroxylase (TH), a marker for terminally differentiated
autonomic neurons, were both present in AG of Ezh2 cko embryos,
as in control embryos (Fig. 2J-O). Similarly, Oct6 (Pou3f1 – Mouse
Genome Informatics), a marker expressed in premature Schwann
cells, was expressed in peripheral nerves of Ezh2 cko mice in a
manner comparable to control peripheral nerves. Mutant peripheral
nerves also stained normally for NF160 (Fig. 2P,Q). Quantification
of the immunohistochemical data confirmed that formation of the
sensory, autonomic and glial lineages was not overtly affected by
the loss of Ezh2 (Fig. 2R-T). Our results indicate, therefore, that
global loss of H3K27me3 in NCCs does not interfere with PNS
differentiation steps.
Ezh2 depletion in NCCs causes severe craniofacial defects
Gross morphological analysis of Ezh2 cko embryos pointed to a
requirement of H3K27me3 for proper BA differentiation and
morphogenesis of craniofacial structures (Fig. 1I,J). To further
investigate this phenotype, we assessed cartilage and bone formation
in Ezh2 cko embryos at different developmental stages. As shown
by Alcian Blue staining, conditional ablation of Ezh2 in NCCs
resulted in loss of all the chondrogenic structures that build up the
skeletogenic elements of the craniofacial structures (Fig. 3A-D). At
E14.5, Ezh2 cko embryos lacked the upper and lower jaws as well
as the nasofrontal plate (Fig. 3C,D). At E17.5, staining with both
Alcian Blue and Alizarin Red (labeling bone) showed that almost
all facial skeletal elements were absent in Ezh2 cko embryos
(Fig. 3E,F). Elements completely derived from CNCCs were absent,
whereas skull bones, to which CNCCs are just beginning to
contribute at this stage, appeared abnormal but were established
(Gross and Hanken, 2008; Jiang et al., 2002). Parts of the parietal
skeletal plate and the interparietal plate were detectable (Fig. 3E,F).
Bones derived exclusively from CNCCs, such as the mandible,
maxillary or the nasofrontal plate, were completely missing in Ezh2
cko embryos at E17.5 (Fig. 3E,F). Chondrogenic elements, such as
the otic capsule, were partially established in the back of the head
(Fig. 3E,F), but, more rostrally, chondrogenic elements failed to
form. The tympanic ring, which is a BA1 derivative, was not
detectable in Ezh2 cko embryos (Fig. 3E-H). Moreover, analysis at
higher magnification revealed that the styloid process, a BA2
derivative, failed to form properly in Ezh2 cko embryos (Fig. 3G,H).
Likewise, the hyoid bone, a BA2 and BA3 derivative, was missing
upon Ezh2 conditional inactivation, as demonstrated by combined
staining for Alcian Blue and Eosin on sagittal sections of embryos
at E17.5 (Fig. 3I,J). Thus, loss of Ezh2-mediated H3K27me3
appears to interfere with the formation of multiple skeletal elements
originating from the NC.
Cell cycle properties and MPC generation are unaffected
upon Ezh2 inactivation
One defining criteria for stem/progenitor cells is their self-renewal
capacity. Ezh2 is known to contribute to cell cycle regulation in
different cell types, including cancer cells (Pasini et al., 2004). We
analyzed the cell cycle properties of MPCs present in the BAs of
Ezh2 cko mice. First, cells undergoing S phase were examined by
EdU pulse labeling 1 hour prior to euthanization at E11.5 (Fig. 4A).
Quantification showed no significant differences in the number of
cells that were positive for EdU in BA1 when comparing control
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Fig. 3. Skeletal analysis reveals a severe craniofacial defect in Ezh2 cko
embryos. (A-D) Analysis of cartilage formation in control and Ezh2 cko
littermate embryos at E14.5 by Alcian Blue staining. No chondrogenic
malformations are observed in the trunk region of Ezh2 cko embryos compared
with control embryos. However, the CNC-derived structures are mostly missing
in Ezh2 cko embryos. (C,D) Higher magnification of the head region of the
embryos shown in A and B, highlighting the absence of CNC-derived
craniofacial structures in Ezh2 cko embryos. (E,F) A comparison between
control and Ezh2 cko embryos at E17.5, with combined staining for Alcian Blue
and Alizarin Red, shows that craniofacial bone elements are missing in Ezh2
cko embryos. Head skeleton structures built by mesodermal cells (rather than
exclusively by CNCCs) are disturbed, but not entirely missing, whereas
structures exclusively originating from CNCCs are missing completely.
(G,H) Comparison at higher magnification of the embryos shown in E and F
reveals that the styloid process, which is a BA2 derivative, is missing in Ezh2
cko embryos, as indicated by the open arrowhead. (I,J) Combined staining for
Alcian Blue and Eosin in sagittal sections suggested that the hyoid bone, a
BA2 and BA3 derivative, is missing in Ezh2 cko embryos, as indicated by the
open arrowhead. ip, interparietal plate; e, exoccipital; nc, nasal capsule; o, otic
capsule; p, parietal plate; f, frontal plate; n, nasal plate; mx, maxillary; md,
mandible; tr, tympanic ring; stp, styloid process; tc, thyroid cartilage; h, hyoid
bone. Scale bars: 2 mm in A-H; 0.5 mm in I,J. 
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with Ezh2 cko mice (46.6% versus 47.8% of cells EdU positive,
respectively). Therefore, S phase entry and exit were unaffected in
cells lacking Ezh2. Next, the number of cells in M phase was
determined by phospho-histone H3 (PHH3) immunohistochemical
staining (Fig. 4B) on BA1 sections of embryos at E11.5. Again, no
significant differences were found between control and Ezh2 cko
animals. BA1 of control and Ezh2 cko animals contained 3.9% and
5.1% PHH3-positive cells, respectively.
To definitively exclude any cell cycle differences between control
and Ezh2 cko MPCs, we performed cell cycle FACS on cells
isolated from BA1 at E11.5. The cell cycle profiles of control and
Ezh2 cko cells were very similar (Fig. 4C). Moreover, no significant
changes in cell cycle progression were detected when the
proportions of cells in different cell cycle phases were calculated for
control and Ezh2 cko embryos at E11.5. For both genotypes, we
found ~31% of the cells in G2 phase and ~38% in G1 phase.
Calculations based on cell cycle FACS further indicated the
proportion of cells in S phase to be ~30% in both cases.
Overall, these results demonstrate that conditional Ezh2
inactivation does not change the cell cycle properties of BA cells,
suggesting that the observed phenotype is not caused by cell cycle
misregulation. Additionally, we did not see differences in the rates
of apoptosis between Ezh2 cko and control embryos at any time
point analyzed (data not shown). Thus, the malformations of
craniofacial bone and cartilage in Ezh2 cko animals are due to a
deficit in Ezh2 functions other than those regulating cell
proliferation and survival.
Ezh2 promotes bone and cartilage formation in CNCCs by
repressing inhibitors of an osteochondrogenic program
We previously demonstrated that the transition from NCSCs,
emigrating from the hindbrain region to populate the BAs, to MPCs
with an osteochondrogenic potential requires the downregulation of
the NCSC transcription factor Sox10 and the simultaneous
upregulation of the MPC marker Sox9 (John et al., 2011). Therefore,
the craniofacial phenotype observed in Ezh2 cko embryos could be
due to a failure of NCSCs to become MPCs. To address this
possibility, we performed immunohistochemical analyses of Sox10+
and Sox9+ cells in BA1 of control and Ezh2 cko embryos at E11.5.
Sox10 was restricted to a few cells, which were unaltered in number
in Ezh2 cko as compared with control embryos (Fig. 5A,B,E). Co-
staining for NF160 suggested that these Sox10+ cells were putative
neural cells associated with nerves in the BA. Unlike Sox10, Sox9
was broadly expressed in both control and mutant BAs, and the
number of Sox9+ cells was also unaffected by the inactivation of
Ezh2 (Fig. 5C-E). Furthermore, quantitative RT-PCR in isolated
BA1 cells did not reveal any statistically significant differences in
the expression of Sox10 and Sox9 between Ezh2 cko embryos and
control littermates (Fig. 5F). Thus, MPCs can apparently form in the
absence of Ezh2 activity.
Next, we investigated whether MPCs lacking Ezh2 are able to
acquire an osteochondrogenic fate. Immunohistochemical analysis
at E11.5 demonstrated that collagen 2a1 (Col2a1) expression, an
early indicator of chondrogenic differentiation, was absent in BA1
of Ezh2 cko embryos, in contrast to control littermates (Fig. 5G,H).
Similarly, expression analysis of early markers of osteogenic and
chondrogenic differentiation revealed that the transcription factors
Runx2 and Osterix (Sp7 – Mouse Genome Informatics), as well as
the osteoblast marker alkaline phosphatase (ALP) (Nishimura et al.,
2012; Oh et al., 2012), were significantly downregulated in Ezh2
cko compared with control BA1, as shown by quantitative RT-PCR
(Fig. 5I). In summary, MPCs with normal cell cycle properties and
a normal Sox factor expression code can be established from NCSCs
lacking Ezh2. However, conditional ablation of Ezh2 prevents the
early steps of the osteochondrogenic differentiation program in
MPCs.
To determine possible mechanisms underlying impaired
chondrogenic and skeletogenic differentiation in Ezh2 cko NC
derivatives, we sought to identify putative Ezh2 target genes. BA1
from control and mutant E11.5 embryos was mechanically
dissected and total RNA isolated. The Affymetrix A430
microarray platform was then used to perform a differential
expression analysis of control versus Ezh2 cko BA1 cells
(Fig. 6A). Clustering of biological replicates demonstrated highly
comparable global gene expression patterns among the same
genotypes, as shown by a heat map of genes that were at least 2-
fold up- or downregulated with P<0.01 (Fig. 6B). Since Ezh2 acts
as a repressor (Margueron et al., 2008), we focused our analysis
871
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Fig. 4. Cell cycle properties of mesenchymal progenitor
cells. (A) Quantification of EdU+ cells in BA1 shows no
significant differences between control and Ezh2 cko
littermates. (B) Quantification of mitotic cells assessed by
PHH3 immunostaining revealed no significant differences
between control and Ezh2 cko embryos. (C) Cell cycle FACS
analysis shows similar profiles for isolated BA1 cells from E11.5
control and Ezh2 cko littermates. No significant differences
were detected for the proportion of cells in different phases of
the cell cycle. The S phase cells of both cell cycle profiles were
computed with FlowJo and the Fox-Dean-Jett algorithm. Bar
charts show mean ± s.e.m. Scale bars: 50 μm.
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on the transcripts upregulated in Ezh2 cko cells. Strikingly, the
expression levels of many Hox gene transcripts were increased in
Ezh2 cko BA1 cells, as particularly evident when a low P-value
(P<0.001) was applied to reveal highly significant differences
between control cells and cells devoid of Ezh2 (Table 1). These
data were corroborated when we increased the P-value (P<0.05)
and found that, with these parameters, 36 out of 39 Hox genes
present on the array were upregulated in Ezh2 cko BA1 cells (data
not shown). The overexpression of Hox genes in mutant cells is
consistent with the described function of the polycomb group
(PcG) complexes in regulating Hox gene expression during
embryonic limb and tail development in mice (Soshnikova and
Duboule, 2009; Wyngaarden et al., 2011). Moreover, several of the
upregulated Hox genes are known to play a role in modulating
osteochondrogenic differentiation in different cellular contexts (see
Table 1). In our transcriptome analysis, Hox gene expression was
upregulated to varying degrees in BA1 cells from Ezh2 cko
embryos as compared with BA1 cells from control littermates
(Table 1). Highly elevated expression levels in Ezh2 cko BAs were
also readily detectable by in situ hybridization on sections of E11.5
control and mutant embryos (supplementary material Fig. S2A-F;
Table S4). To validate these results, we performed quantitative RT-
PCR and confirmed the significant increase in expression
(P<0.001) of selected Hox genes in Ezh2 cko versus control BA1
cells (Fig. 6C). Of note, equivalent expression analysis for the
same genes failed to show broadly increased expression of Hox
genes in the trunk of Ezh2 cko (supplementary material Fig. S2G),
suggesting that Hox gene derepression following loss of Ezh2
activity is restricted to cranial NC derivatives.
To address whether Hox genes are direct targets of Ezh2-mediated
H3K27 trimethylation in BA1 cells, rather than being upregulated
due to secondary effects, we performed chromatin
immunoprecipitation (ChIP) for H3K27me3 and measured the
abundance of DNA occupied by H3K27me3 with primers targeting
the transcription start sites of the selected Hox genes. Int1, which is
an intergenic region devoid of H3K27me3, was used as a negative
control. All of the Hox genes analyzed were found to be modified
by H3K27me3 in BA1 cells (Fig. 6D). Thus, multiple Hox genes are
direct targets of Ezh2-mediated H3K27me3 in wild-type BA1 cells.
Hence, the conditional depletion of Ezh2 leads to the derepression
of many Hox genes, thereby activating numerous well-established
suppressors of osteochondrogenesis.
DISCUSSION
In the present study we demonstrate that the PcG protein Ezh2 is a
key regulator of CNCC development and is crucial for CNCCs to
acquire a chondrogenic and osteogenic fate. Indeed, Ezh2
conditional ablation and concomitant loss of Ezh2-mediated H3K27
trimethylation in the NC resulted in agenesis of all NC-derived
craniofacial structures. Surprisingly, however, Ezh2 inactivation in
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Fig. 5. Osteochondrogenic progenitor establishment and differentiation are impaired in Ezh2 cko mice. (A-D) Immunohistochemistry reveals that, by
E11.5, both control and Ezh2 cko BA1 cells have lost the expression of the NCSC marker Sox10 and acquired the expression of the mesenchymal progenitor
marker Sox9. The few remaining Sox10+ cells are associated with nerves, as evidenced by neurofilament (NF) staining (A,B). (E) Quantification of Sox10+ and
Sox9+ cells in BA1 revealed no significant differences between control and Ezh2 cko embryos. Data are the mean percentage of positive cells/DAPI ± s.e.m.
(F) Quantitative RT-PCR in E11.5 control and Ezh2 cko BA1 cells shows no significant change in the mRNA expression of Sox10 and Sox9. Data are
presented as mean fold change ± s.e.m. (G,H) Immunohistochemistry shows the absence of chondrocyte marker Col2a1 expression in Ezh2 cko BA1 cells.
(I) Quantitative RT-PCR for chondro/osteogenesis markers expressed at different stages of chondro/osteogenic differentiation, showing impaired
chondro/osteoblast establishment. The expression differences in BA1 cells of control and Ezh2 cko littermates were significant (*P<0.05). Data are presented
as mean fold change ± s.e.m. Scale bars: 50 μm.
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the NC did not cause any overt glial or neuronal defects in the PNS,
indicating distinct requirements of epigenetic control mechanisms
by different NCC lineages. The only cells with an NC origin that are
capable of giving rise to craniofacial skeletal elements are located
anterior to or in BA1, BA2, BA3 and BA4. Previously, it has been
shown that the capacity of BA1 cells for osteochondrogenesis is
dependent on the absence of Hox gene expression (Minoux et al.,
2009). As shown here, conditional deletion of Ezh2 in the NC led to
strong upregulation and misexpression of multiple Hox genes in BA
cells. Furthermore, we identified Hox genes as direct targets of
H3K27me3-dependent transcriptional repression in CNCCs. Thus,
the derepression of multiple Hox genes appears to play a major role
in preventing osteochondrogenesis in NCCs lacking Ezh2. Our
findings reveal a crucial role of epigenetic gene silencing in
regulating the formation of the jaw and other craniofacial skeletal
elements from NCCs.
NCSC proliferation and PNS formation appear not to be
affected upon conditional Ezh2 inactivation
Ezh2 has been indicated as a modulator of cell cycle progression
(Chen et al., 2010; Kaneko et al., 2010; Zeng et al., 2011) and
controls the maintenance and proliferation of a variety of stem cell
types in normal tissue and cancer (Bracken et al., 2006; Ezhkova et
al., 2009; Herrera-Merchan et al., 2012; Juan et al., 2011; McCabe
et al., 2012; Pereira et al., 2010; Qi et al., 2012; Suvà et al., 2009).
By contrast, the number of NCCs emigrating from the neural tube
and localizing to NC target structures was not subject to Ezh2-
dependent regulation. In fact, NC-specific Ezh2 ablation did not
result in any changes in the cell cycle profile of NC-derived cells.
These results indicate that the function of Ezh2 as a cell cycle
modulator is tissue specific. Moreover, our data reveal that Ezh2 has
a major role in NCCs at relatively late stages of NC development,
after NC specification and migration.
Surprisingly, loss of Ezh2 in NCCs also appeared not to affect the
formation of neurons and glia in peripheral ganglia and nerves. This
is somewhat different to the situation in the CNS, where Ezh2
controls the choice between proliferation and neuronal
differentiation, as well as the timely fate switch from neurogenesis
to gliogenesis (Hirabayashi et al., 2009; Pereira et al., 2010). By
contrast, dorsal root and autonomic ganglia of Ezh2 cko embryos
contained normal numbers of sensory and autonomic neurons,
respectively. Likewise, differentiation and the timely appearance of
satellite glia in ganglia and Schwann cells along peripheral nerves
were unaffected in Ezh2 cko compared with control embryos. Taken
together, the generation and differentiation of neural lineages from
NCCs are apparently not dependent on Ezh2-mediated epigenetic
gene regulation. Interestingly, Shen and colleagues (Shen et al.,
2008) have previously reported lineage-specific requirements for
Ezh2 during differentiation of mESCs. Ezh2 ablation in ESCs
induced neural/ectoderm lineages at the expense of the mesodermal
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Fig. 6. Hox family genes suppressing
osteochondrogenesis are Ezh2 targets and
strongly upregulated upon Ezh2 inactivation. An
illustration of the workflow for isolation of BA1 cells
from E11.5 control and Ezh2 cko embryos for
microarray and RT-PCR expression analysis.
(B) Microarray gene expression heat map of BA1 cells
isolated from control and Ezh2 cko littermates. The
signature used in the heat map was compiled from
Affymetrix probe sets and shows transcripts that are
differentially expressed when applying a fold change of
at least 2-fold with P<0.01. (C) Quantitative RT-PCR
for seven selected Hox genes. BA1 cells of Ezh2 cko
embryos showed significantly higher Hox gene
expression than control BA1 cells, suggesting Hox
derepression in Ezh2 cko embryos. Data are
presented as mean of fold change ± s.e.m.
***P<0.001, **P<0.01, *P<0.05. (D) ChIP performed to
confirm H3K27me3 occupancy in a region around the
transcription start site (±500 bp) of selected Hox genes
in isolated chromatin from BA1 cells of E11.5 embryos.
Data are presented as mean of fold enrichment over
input ± s.e.m.
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and endodermal differentiation programs. This suggests that the
endodermal and mesodermal lineages are more susceptible to
changes in Ezh2 activity than are neural lineages (Shen et al., 2008).
Our findings are consistent with this hypothesis: neural lineage
formation remained unaffected upon inactivation of Ezh2 in the NC,
whereas the development of NC-derived mesenchymal progenitors,
which adopt a differentiation program similar to that of the
mesoderm in vivo, was severely hampered in mutant mice.
An alternative explanation for unimpaired PNS development in
Ezh2 cko embryos is that, in the PNS, Ezh1 activity might compensate
for the loss of Ezh2 by catalyzing the methylation mark on H3K27,
but fails to do so in cranial NC-derived MPCs. Others have previously
demonstrated that, upon loss of Ezh2, Ezh1 can take over the catalytic
function of Ezh2 for a particular subset of genes crucial for
development (Boyer et al., 2006; Ezhkova et al., 2011). However, in
the present study, conditional deletion of Ezh2 was accompanied by a
major loss of H3K27me3 in migratory trunk NCCs at early
developmental stages and in all NC derivatives analyzed, including
PNS structures, suggesting that Ezh1 was unable to assume Ezh2
functions in a global manner in mutant NCCs. Nonetheless, we cannot
rule out that a subset of genes crucial for neurogenesis remains
occupied by H3K27me3 in Ezh2 cko embryos due to Ezh1
compensation, allowing for normal PNS development. Furthermore,
distinct epigenetic silencing mechanisms (e.g. H3K9 trimethylation
and/or DNA methylation, in addition to H3K27 trimethylation) might
have redundant functions in repressing gene expression during PNS
development. Conceivably, however, loss of Ezh2 and H3K27me3
leads to gene derepression also in the PNS, but these genes encode
factors that apparently do not interfere with neuronal and glial
differentiation programs when overexpressed.
Ezh2 is required for craniofacial chondrogenesis and
osteogenesis
In contrast to PNS development, Ezh2 activity is indispensable for
osteochondrogenesis and thus for the formation of the craniofacial
skeletal elements originating from the NC. During development,
NCSCs originating in the cranial NC undergo a transition to MPCs,
thereby losing neural potential and, at the same time, gaining the
potential to produce mesenchymal lineages (John et al., 2011). This
developmental switch is characterized by downregulation of the
transcription factor Sox10 and concomitant upregulation of the
transcription factor Sox9. Sox9 has been implicated in craniofacial
development (Mori-Akiyama et al., 2003), although its conditional
ablation in the NC resulted in a much less severe phenotype than
exhibited by Ezh2 cko embryos. One possible explanation for the
craniofacial phenotype observed upon Ezh2 ablation is a failure of
mutant NCSCs to give rise to MPCs. However, analysis of Sox9 and
Sox10 expression levels did not reveal statistically significant changes
upon Ezh2 inactivation. By contrast, early stages of chondrogenesis
were impaired in Ezh2 cko embryos, as indicated by the lack of Col2a1
in mutant BA cells. Additionally, other chondrogenic and osteogenic
markers, such as Runx2, Osterix and ALP, failed to be expressed by
BA cells upon Ezh2 deletion. Our findings show that MPC identity can
be established in the absence of Ezh2-mediated H3K27me3. However,
Ezh2 inactivation prevents MPCs from acquiring an osteochondrogenic
fate and, hence, producing cartilage and bone.
Ezh2 activity silences Hox gene expression in CNCCs
Craniofacial skeletal elements originating from the NC are
exclusively produced from areas anterior to or located in BA1, BA2,
BA3 and BA4, and NCCs posterior to these structures do not give
rise to cartilage or bone. Moreover, CNCCs that populate the BA1
and the nasofrontal areas must have a Homeobox-free ground
pattern to undergo both forms of osteogenesis, i.e. endochondral and
intramembranous ossification (Santagati and Rijli, 2003; Kanzler et
al., 1998). BA2 cells express a single Hox gene, Hoxa2, and only
undergo endochondral ossification (Kanzler et al., 1998; Minoux et
al., 2009; Santagati and Rijli, 2003). NCCs more caudal to BA2 are
characterized by expression of several Hox genes and display a
well-defined Hox gene expression code that varies according to the
anterior-posterior position. Many Hox factors have been shown to
suppress osteochondrogenesis, hence restricting this potential to
anterior NC populations (Couly et al., 1998; Kanzler et al., 1998;
Yueh et al., 1998; Creuzet et al., 2002).
Large-scale analysis of ESCs has previously shown that Ezh2
occupancy, although widespread in the genome, is not global, but
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Table 1. Hox gene derepression in Ezh2 cko BA1 cells
Gene symbol Ratio P-value References
Hoxa9 134.3 1.43×10–9 Shi et al., 2001
Hoxa10 104.2 1.79×10–11 Hassan et al., 2007
Hoxc8 56.2 3.12×10–9 Yueh et al., 1998
Hoxb3 21.7 3.11×10–8 Manley and Capecchi, 1997
Hoxd13 21.5 1.01×10–8 Chae et al., 2008
Hoxc10 15.4 7.08×10–6 Hostikka et al., 2009
Hoxc4 12.1 4.17×10–8
Hoxa11 10.5 2.14×10–6 Gross et al., 2012
Hoxb13 10.2 4.03×10–7
Hoxa2 8.5 3.14×10–8 Kanzler et al., 1998; Couly et al., 1998; Creuzet et al., 2002
Hoxa5 5.0 1.51×10–4
Hoxc9 4.3 1.78×10–8
Hoxa3 4.1 1.23×10–4 Creuzet et al., 2002; Manley and Capecchi, 1997
Hoxc5 3.5 6.58×10–6
Hoxc13 2.6 2.73×10–5 Chae et al., 2008
Hoxd8 2.5 4.62×10–5
Hoxa1 2.4 1.21×10–6
Hoxb2 2.1 2.22×10–5
Hoxa7 2.1 6.43×10–6
Hoxb4 2.0 1.12×10–4 Couly et al., 1998; Creuzet et al., 2002
Hox genes from the microarray that are derepressed in Ezh2 cko BA1 cells in a highly significant manner, with upregulation of at least 2-fold and P<0.001.
References are listed that describe an involvement of the respective Hox gene in chondrogenesis or osteogenesis. Hoxa2, Hoxa3 and Hoxb4 have been
described to block skeletogenesis specifically in CNCCs. D
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rather is mostly associated with development-related genes (Boyer
et al., 2006). Among these, the Hox gene cluster was found to be
prominently regulated by Ezh2 in ESCs. Likewise, Hox genes are
well-established targets of polycomb regulation in Drosophila
(Ringrose and Paro, 2004; Sparmann and van Lohuizen, 2006).
Interestingly, our microarray analysis demonstrated that, also in BA1
cells isolated from Ezh2 cko embryos, many Hox genes are heavily
upregulated when compared with control embryos. Therefore,
massive Hox gene misexpression, probably in conjunction with
misregulation of other Ezh2 target genes, might be a major cause of
the craniofacial defects observed upon loss of Ezh2 and H3K27me3
in NCCs.
Indeed, several reports have suggested that erratic Hox gene
expression causes impaired chondrogenesis and osteogenesis. For
instance, Hoxa2, which is overexpressed in BA1 cells of Ezh2 cko
embryos, is a well-known inhibitor of intramembranous bone
formation from BAs, and when overexpressed in the Hox-negative
domain of avian embryos impairs formation of the facial skeleton
(Couly et al., 1998; Creuzet et al., 2002; Kanzler et al., 1998).
Massip and colleagues have shown that ectopic expression of Hoxa2
in chondrocytes results in impaired differentiation, as demonstrated
by the lack of Col2a1, and prevents cartilage formation (Massip et
al., 2007). In BA2, Hoxa2 is a promoter of the hyoid fate of
mesenchymal CNCCs and restricts the chondrogenic domains that
arise during endochondral ossification (Pasqualetti et al., 2000).
Hoxa2 gain-of-function in BA1 cells results in a duplication of BA2
skeletal elements in Xenopus (Pasqualetti et al., 2000), whereas
Hoxa2 loss in BA2 in mice leads to a mirror homeotic
transformation of BA1 skeletal elements (Rijli et al., 1993).
Importantly, Hoxa2 in BA2 prevents osteogenesis by blocking its
main effector, Runx2. In addition, Hoxa2 is also involved in
cartilage patterning until E11.5 by an independent mechanism that
involves different co-factors. Conditional gene inactivation further
revealed that subpopulations of CNCCs require Hoxa2 at defined
time points for proper BA patterning (Santagati et al., 2005). Hoxc8
is another factor that prevents endochondral differentiation by
maintaining chondrocytes in a proliferative state and inhibiting
chondrocyte hypertrophy (Yueh et al., 1998). Furthermore, Hoxa9
is known to be a direct repressor of the earlier bone inducer
osteopontin in lung epithelial cell lines (Shi et al., 2001).
Interestingly, Hoxa10 contributes to the onset and maintenance of
osteogenesis by activating Runx2 and osteoblast-specific genes
(Hassan et al., 2007). Finally, Hoxa3 and Hoxb4 are also well-
known inhibitors of osteogenesis in NC precursor cells. When
individually overexpressed in NC derivatives of chicken embryos,
Hoxa3 expression results in the formation of rudimentary
nasofrontal bud derivatives, whereas Hoxb4 impairs terminal
differentiation of BA1 derivatives such as the proximal bones
(Couly et al., 1998; Creuzet et al., 2002). However, when jointly
overexpressed, Hoxa3 and Hoxb4 block skeletogenesis to a similar
extent as ectopic Hoxa2 expression.
All these data indicate that NC precursors are specified for
osteochondrogenesis in a temporally controlled manner, and that
finely tuned regulation of Hox gene expression is crucial for this
process. In BAs of Ezh2 cko embryos, high and ectopic expression
of the Hox genes mentioned above to suppress osteogenesis and
chondrogenesis, as well as of many other Hox genes, is associated
with the inhibition of chondrogenic and osteogenic gene expression
programs and a virtually complete blockage of cartilage and bone
formation from NCCs. By contrast, Ezh2 inactivation in trunk NC
does not lead to profound changes in Hox gene expression or the
overt malformation of neural lineages. Thus, Ezh2-mediated H3K27
trimethylation plays a lineage-specific role in NCCs, repressing Hox
genes in anterior NC subpopulations and thus allowing
osteochondrogenesis in these cells. Clearly, region-specific Hox
gene regulation and the potential to form skeletal structures must
involve other factors as well, given that Ezh2 and H3K27me3 are
also broadly expressed in more posterior NCCs, which in vivo do
not form cartilage and bone. These factors include intrinsic cues that
distinguish CNCCs from more caudal NCCs, as suggested, for
example, by clonal assays in cell culture or by the in vivo
manipulation of signaling pathways regulating neural and
osteochondrogenic fates (Büchmann-Møller et al., 2009; Calloni et
al., 2009; John et al., 2011). The nature of these cues and their
potential functional interaction with epigenetic regulators, including
Ezh2, remain to be determined. Moreover, our study raises the
intriguing question of whether and how epigenetic control of
osteochondrogenesis in NCCs was involved in the evolution of
jawed vertebrates.
MATERIALS AND METHODS
Animals and genotyping
The Cre-loxP system was used to conditionally ablate Ezh2 in NCCs. Mice
carrying a transgene, in which two exons encoding the SET domain of Ezh2
are flanked by loxP sites, have been described (Hirabayashi et al., 2009).
Homozygous animals (Ezh2lox/lox) were crossed with animals carrying the
Wnt1-Cre transgene (Danielian et al., 1998). Offspring with the genotype
Wnt1-Cre; Ezh2lox/lox were termed Ezh2 cko and compared with their
respective littermates having either no Wnt1-Cre transgene (Ezh2lox/lox or
Ezh2lox/wt) or lacking a second copy of the floxed Ezh2 transgene (Wnt1-Cre,
Ezh2lox/wt). Such control animals never showed an overt phenotype and
displayed normal life expectancy. Timed matings were performed overnight
(o/n) and noon on the following day was considered E0.5. In vivo fate
mapping of NCCs was performed on mice additionally carrying the R26R-
lacZ allele (Soriano, 1999). Genotyping was by PCR on genomic DNA
obtained from tails. Primers are listed in supplementary material Tables S1
and S1.1. All animal experiments were conducted in accordance with the
Veterinary Office of the Canton of Zurich, Switzerland.
Immunohistochemistry, X-Gal staining and EdU staining
For immunohistochemistry, cryosections were processed as previously
described (John et al., 2011). Primary antibodies were used as follows: rabbit
anti-PHH3 (1:200; Millipore, 06-570), mouse anti-tyrosine hydroxylase
(TH) (1:200; Sigma, T1299), mouse anti-Mash1 (1:100; BD Biosciences,
556604), rabbit anti-Brn3a (1:2000; a gift from E. E. Turner, Seattle
Children’s Research Institute, Seattle, WA, USA), mouse anti-NF160 (1:400;
Sigma, N-5264), rabbit anti-NF160 (1:200; Chemicon, AB1987), rabbit anti-
Ki67 (1:200; Abcam, ab 15580), rabbit anti-cleaved caspase 3 (1:200; Cell
Signaling, 9661), rabbit anti-H3K27me3 (1:200; Millipore, 07-449), rabbit
anti-Oct6 (1:200; gift from Dies Meijer, Erasmus University, Rotterdam, The
Netherlands), rabbit anti-Col2a1 (1:200; Acris, R1039X), goat anti-Sox10
(1:100; Santa Cruz, sc-17342), rabbit anti-Sox9 (1:50; Santa Cruz, sc-20095)
and chicken anti-β-galactosidase (1:200; Abcam, ab 9361). Secondary
antibodies were from Jackson ImmunoResearch or Invitrogen. lacZ reporter
gene expression was detected as previously described (Hari et al., 2012).
EdU stainings were performed according to the manufacturer’s protocols
(Invitrogen). EdU was injected intraperitoneally 1 hour before euthanization
of time-mated animals at E11.5.
Isolation and preparation of BA1 cells
BA1 cells were isolated from embryos as described (John et al., 2011). For
mRNA isolation (microarray analysis and quantitative RT-PCR) we used the
RNeasy Mini Kit (Qiagen). For ChIP we followed the protocol of Weber et
al. (Weber et al., 2007).
Cell cycle FACS analysis
Wnt1-Cre; Ezh2lox/lox and Ezh2lox/lox BA1 cells were taken up in 500 μl PBS
containing 1.25 mM 5-AAD (Sigma), washed twice in PBS and then
875
RESEARCH ARTICLE Development (2014) doi:10.1242/dev.094342
D
ev
el
op
m
en
t
876
analyzed using a FACS Canto II flow cytometer (BD Biosciences). FlowJo
software (Tree Star) was used to analyze the data and for quantification. The
quantification (Fig. 4D) was performed with the Dean-Jett-Fox algorithm
(Fox, 1980) provided by FlowJo.
Quantitative RT-PCR and ChIP-quantitative PCR
Total mRNA (0.5 μg) from BA1 cells served as template for reverse
transcription with oligo(dT) primers (Invitrogen) and superscript III reverse
transcriptase (Invitrogen). The quantitative PCR reaction was performed on
a LightCycler II (Roche). For ChIP samples, 1 μl of ChIP samples or input
DNA was used per PCR reaction. Each experiment was performed in
triplicate and three independent quantitative PCR reactions were then
analyzed using the ΔCt method. β-actin was used for normalization. Primers
are listed in supplementary material Tables S2 and S3.
Alcian Blue and Alizarin Red staining
Alcian Blue (Fluka) and Alizarin Red (Chroma) stainings followed
published protocols (Nagy, 2003).
Microarray
After mRNA extraction we submitted the samples to the Functional
Genomics Center Zurich (FGCZ) for processing. The Affymetrix A430
platform was used to compare transcriptional differences between Wnt1-Cre;
Ezh2lox/lox and Ezh2lox/lox BA1 cells. The array was uploaded to Gene
Expression Omnibus with accession number GSE52220.
Statistical analyses
Each experiment was performed using at least three different embryos.
Statistical significance was tested with an unpaired, two-tailed Student’s t-
test.
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